Shares of Dr. Reddy's Laboratories extended losing streak for the third straight session on Monday, falling over 3 per cent on the Bombay stock Exchange after the drug maker’s net profit declined more than half to Rs 59 crore in Q1FY18 from Rs 126 crore in the same quarter year ago.
Continuing its losing spree, shares of the company declined as much as 3.12 per cent to hit intra-day low of Rs 2385.10 apiece on the Bombay Stock Exchange. The stocks were currently trading at Rs 2389 against previous close price of Rs 2462.05.
In a similar fashion, shares of the pharma company were trading 3.05 per cent lower at Rs 2,389.85 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 32,468.61, up 158.73 points, or 0.49 per cent, at 13:05 hours.